According to Zosano Pharma's latest financial reports the company's current EPS (TTM) is -$9.45. In 2021 the company made an earnings per share (EPS) of -$9.45 an increase over its 2020 EPS that were of -$17.15.
Year | EPS | Change |
---|---|---|
2021 | -$9.45 | -44.9% |
2020 | -$17.15 | -78.6% |
2019 | -$80.15 | -38.77% |
2018 | -$130.90 | -77.76% |
2017 | -$588.71 | -61.24% |
2016 | -$1,519 | -12.85% |
2015 | -$1,743 | 112.54% |
2014 | -$820.10 | 10.52% |
2013 | -$742.01 | -403.82% |
2012 | $244.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Baxter BAX | $5.12 | -154.18% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | -$5.64 | -40.32% | ๐บ๐ธ USA |